Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 10
- Registration Number
- NCT00003111
- Locations
- 🇺🇸
Yale Comprehensive Cancer Center, New Haven, Connecticut, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- UNICANCER
- Target Recruit Count
- 350
- Registration Number
- NCT00003652
- Locations
- 🇫🇷
Centre Paul Papin, Angers, France
🇫🇷Centre Regional Francois Baclesse, Caen, France
🇫🇷Centre Hospitalier, Chalon Sur Saone, France
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 819
- Registration Number
- NCT00028743
- Locations
- 🇨🇦
Lions Gate Hospital, North Vancouver, British Columbia, Canada
🇨🇦CancerCare Manitoba, Winnipeg, Manitoba, Canada
🇨🇦BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT00052429
- Locations
- 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-02-11
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 216
- Registration Number
- NCT00002546
- Locations
- 🇺🇸
UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Women's Cancer Center - Los Gatos, Los Gatos, California, United States
🇺🇸Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, Orange, California, United States
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00004917
- Locations
- 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇺🇸Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸St. Agnes Cancer Center, Baltimore, Maryland, United States
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Radiation Therapy Oncology Group
- Registration Number
- NCT00003862
- Locations
- 🇺🇸
McLaren Regional Cancer Center, Flint, Michigan, United States
🇺🇸Ireland Cancer Center, Cleveland, Ohio, United States
🇺🇸Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-08-02
- Target Recruit Count
- 285
- Registration Number
- NCT00028756
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 12
- Registration Number
- NCT00006389
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-08-05
- Target Recruit Count
- 704
- Registration Number
- NCT00003636
- Locations
- 🇬🇧
University College of London Hospitals, London, England, United Kingdom
🇨🇦Doctor H. Bliss Murphy Cancer Centre, St. Johns, Newfoundland and Labrador, Canada
🇦🇹Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, Austria
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.